Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,489,727
+$10,210,924 QoQ
Shares Held
3,530,991
+47.9% QoQ
Ownership
2.87%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 147 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CCCC ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CCCC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,489,727 | 3,530,991 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,278,803 | 2,387,378 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,080,028 | 1,089,020 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $1,020,962 | 459,893 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,258,768 | 880,258 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $996,352 | 622,720 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,065,157 | 573,655 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,883,355 | 505,852 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,408,797 | 737,835 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,467,747 | 1,281,242 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $641,347 | 113,513 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $406,824 | 218,723 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $634,056 | 230,566 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,085,129 | 345,583 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,675,316 | 283,952 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,690,792 | 420,843 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $993,198 | 131,724 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,906,080 | 119,789 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,240,105 | 224,848 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $11,793,911 | 263,964 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,739,639 | 230,963 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $418,233 | 12,624 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||